Suchen
Mainz Biomed N V Ord Shs
QUCYZur Watchlist hinzufügen
0.684USD
-0.030-4.20%
Handelsschluss 11-09 16:00（ET）
59.66MMarktkapitalisierung
0.00KGV TTM
Über Mainz Biomed N V Ord Shs Unternehmen
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed N V Ord Shs Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von Mainz Biomed N V Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Elliot Lazar
Mr. David Elliot Lazar
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
55.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
Non-Executive Independent Director
Non-Executive Independent Director
252.00K
+44.79%
Mr. David Natan
Mr. David Natan
Non-Executive Independent Director
Non-Executive Independent Director
137.14K
--
Mr. Peter O'Rourke
Mr. Peter O'Rourke
Independent Director
Independent Director
137.14K
--
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Elliot Lazar
Mr. David Elliot Lazar
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
55.06M
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
Non-Executive Independent Director
Non-Executive Independent Director
252.00K
+44.79%
Mr. David Natan
Mr. David Natan
Non-Executive Independent Director
Non-Executive Independent Director
137.14K
--
Mr. Peter O'Rourke
Mr. Peter O'Rourke
Independent Director
Independent Director
137.14K
--
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Mainz Biomed N V Ord Shs?
Die fünf größten Anteilseigner von Mainz Biomed N V Ord Shs sind: Mr. David Elliot Lazar